Lab
Em1 Labs, LLC
Em1 Labs, LLC was paid $190K by Medicaid between Mar 2018 and Jan 2019, across 14 billing codes. Its largest line is 81317, — 23% of everything it billed.
33Billing provider infoEM1 LABS, LLC
FORT LAUDERDALE, FL 33309
FORT LAUDERDALE, FL 33309
33aNPI1346641875assigned 09/16/2014
33bProvider typeClinical Medical Laboratory
28Total paid$190K
24GClaims5,534
24DCodes billed14
24AFirst – last monthMar 2018 – Jan 2019
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#84 of 225
Median peer was paid$74K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,264 | $104K | |
| 2019 | 3,270 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81317 | 23% | 357 | 180 | $44K | |
| 81292 | 22% | 340 | 168 | $43K | |
| 81298 | 21% | 340 | 168 | $41K | |
| 81321 | 20% | 340 | 168 | $38K | |
| 81295 | 13% | 340 | 168 | $24K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 143 | 29 | $625.95 |
| 81201 | 0% | 357 | 180 | $0.00 | |
| 81479 | Unlisted molecular pathology procedure | 0% | 339 | 168 | $0.00 |
| 81406 | 0% | 702 | 180 | $0.00 | |
| 81404 | 0% | 705 | 180 | $0.00 | |
| 81405 | 0% | 703 | 180 | $0.00 | |
| 81408 | 0% | 360 | 180 | $0.00 |
2 more codes
| 81403 | 0% | 340 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 168 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSKULAS, ANGELO (OWNER (CFO))